MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $153,000 | -34.9% | 59,002 | -20.9% | 0.00% | – |
Q3 2020 | $235,000 | -40.8% | 74,595 | -22.4% | 0.00% | -100.0% |
Q2 2020 | $397,000 | +112.3% | 96,147 | -17.0% | 0.00% | – |
Q1 2020 | $187,000 | -34.8% | 115,840 | 0.0% | 0.00% | – |
Q4 2019 | $287,000 | -26.2% | 115,840 | -50.0% | 0.00% | -100.0% |
Q3 2019 | $389,000 | – | 231,680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
Artal Group S.A. | 1,000,000 | $244 | 0.01% |
Annandale Capital, LLC | 100,000 | $24 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |